Goldman Sachs’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Goldman Sachs’s Portfolio RGDX Stock Details RGDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-67,048	Closed	-$22K	–	7776
2015 Q2	$22K	Sell	67,048 -1	-0%	–	﹤0.01%	7070
2015 Q1	$30K	Sell	67,049 -300	-0.4%	-$134	﹤0.01%	6836
2014 Q4	$21K	Sell	67,349 -2,900	-4%	-$1.6K	﹤0.01%	6983
2014 Q3	$48K	Sell	70,249 -162	-0.2%	-$127	﹤0.01%	6828
2014 Q2	$65K	Buy	70,411 +35,287	+100%	+$36.9K	﹤0.01%	6694
2014 Q1	$42K	Buy	35,124 +14,213	+68%	+$19.8K	﹤0.01%	6606
2013 Q4	$24K	Buy	+20,911	New	+$34.3K	﹤0.01%	6522

Goldman Sachs's RGDX Position: Q3 2015 in Review

Goldman Sachs sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 67,048 shares — an estimated $22K sold.

Goldman Sachs first reported a position in RGDX in Q4 2013 and held it in 7 quarters. The position peaked at $65K in Q2 2014. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

Goldman Sachs reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
Goldman Sachs sold 67,048 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015, an estimated $22K.
Goldman Sachs first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q4 2013 and held it in 7 quarters.
Goldman Sachs's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $65K in Q2 2014.
1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on Goldman Sachs's 13F filing for Q3 2015, filed 13 Nov 2015.